Search

everythinglearnresearchcommunity

for

Search:↓

Rigenera® effectively improves hair condition in Androgenetic Alopecia, and HairMetrix® tracks progress well.

Mental health issues affect adaptation in alopecia patients more than the cause of hair loss.

Individualized treatment improves symptoms and quality of life for women with PCOS.

Higher stress levels may worsen alopecia areata, suggesting stress management is important for treatment.

Calprotectin levels are higher in alopecia areata patients, indicating systemic inflammation.

Plasmatherapy improves immune status in vitiligo patients, especially those with segmental vitiligo.

Higher levels of IL-17A and IL-2 are linked to alopecia areata.

Stopping nalfurafine reversed hair loss in a hemodialysis patient.

Fungal infections are the most common skin issue in the region.

Early detection and targeted management are crucial for better outcomes in systemic lupus erythematosus.

Baricitinib improves quality of life and reduces anxiety and depression in severe alopecia areata patients with hair regrowth.

COVID-19 can cause various skin issues, like rashes and hair loss, which help in early diagnosis.

Secukinumab can cause hair loss, which may improve after stopping the medication.

Quadruple-coated probiotics significantly improve IBS symptoms.

Low ferritin levels are linked to increased hair loss; no link found between vitamin B12, TSH levels, and hair loss.

These specific gene polymorphisms are not linked to Alopecia Areata in Egyptians.

Platelet-Rich Plasma (PRP) may increase hair density and thickness in Androgenetic Alopecia, but it's not significantly better than a placebo.

Janus kinase inhibitors are effective and generally safe for treating hair loss in adults with alopecia areata.

Interferon beta treatment in MS patients can cause skin reactions and increased hair loss.

PCOS is linked to a higher risk of endometrial cancer but not ovarian or breast cancer, and more research is needed on its role in cancer development and treatment effects.

Early diagnosis and treatment of alopecia areata in children is crucial to prevent severe progression.

Tofacitinib helped regrow hair in most patients with severe hair loss.

Liquid nitrogen cryotherapy worked well for many patients with stubborn alopecia areata.

Lower zinc levels are linked to more severe hair loss in alopecia areata.

Androgenetic alopecia with telogen effluvium is the most common hair loss in women with hirsutism.

Acupressure improves quality of life in PCOS patients.

No single biomarker is reliable enough for diagnosing and assessing SLE.

Cyproterone acetate improves skin symptoms and quality of life in women with androgen-related issues.

Prolactin levels and gene polymorphism are not linked to vitiligo severity but are related to BMI.

Tofacitinib may effectively regrow hair in alopecia totalis patients.